What is the appropriate dosing and titration of Lantus (insulin glargine) for a 60‑kg adult patient already on metformin?

Dosing and Titration of Lantus (Insulin Glargine) for a 60-kg Adult on Metformin

For a 60-kg adult patient with type 2 diabetes already on metformin, start Lantus at 10 units once daily (or 0.2 units/kg = 12 units) and titrate by 2 units every 3 days based on fasting glucose until reaching a target of 90-150 mg/dL. 1

Initial Dosing

The FDA-approved starting dose for insulin-naive type 2 diabetes patients is 1:

• 10 units once daily, OR
• 0.2 units/kg once daily (which equals 12 units for a 60-kg patient)

Continue metformin when adding basal insulin—do not discontinue it 2, 3. The 2024 ADA guidelines explicitly state that metformin should be maintained when initiating insulin therapy in older adults with eGFR ≥45 mL/dL 3.

Timing of Administration

• Administer once daily at the same time each day 1
• Can be given at any time of day, though morning administration is often preferred in older adults to simplify regimens 2, 3
• Rotate injection sites within the same region (abdomen, thigh, or deltoid) 1

Titration Protocol

Use a structured titration algorithm based on fasting glucose monitoring 4:

Standard Approach (from 2025 ADA Guidelines):

• Target fasting glucose: 90-150 mg/dL (5.0-8.3 mmol/L) 3, 5
• If ≥50% of fasting values are above goal: Increase by 2 units 3, 5
• If >2 fasting values/week are <80 mg/dL: Decrease by 2 units 3, 5
• Reassess every 3-6 months and adjust to avoid therapeutic inertia 4

Alternative Evidence-Based Titration (Treat-to-Target Protocol):

Based on mean fasting glucose over 3 days 6:

• ≥100-<120 mg/dL: Increase by 0-2 units
• ≥120-<140 mg/dL: Increase by 2 units
• ≥140-<180 mg/dL: Increase by 4 units
• ≥180 mg/dL: Increase by 6-8 units

Expected Dose Range

Research evidence suggests final doses typically reach 7, 8:

• 0.37-0.40 units/kg/day when combined with metformin
• For a 60-kg patient: approximately 22-24 units daily at steady state
• Higher doses may be needed if A1C remains elevated

Critical Safety Considerations

Hypoglycemia Prevention:

• Most common adverse reaction with all insulins 1
• Risk increases with intensive control 1
• Educate patient on recognition and management 1
• Consider less stringent targets (fasting 90-150 mg/dL) in older adults to reduce hypoglycemia risk 2, 3

Administration Warnings:

• Never administer intravenously or via insulin pump—subcutaneous only 1
• Do not dilute or mix with other insulins 1
• Do not share pens or needles between patients 1

When to Intensify Beyond Basal Insulin

If A1C remains above goal after optimizing basal insulin (typically when dose exceeds 0.5 units/kg/day or ~30 units for this patient) 4:

1. First option: Add a GLP-1 receptor agonist (preferred if no contraindications) 4
2. Second option: Add prandial insulin before the largest meal 9, 4
3. Consider switching to premixed insulin if simpler regimen needed 9

Special Populations

Older Adults:

The 2024 ADA guidelines emphasize simplification for older adults 3, 5:

• Use morning dosing to reduce nocturnal hypoglycemia risk
• Target fasting glucose 90-150 mg/dL (less stringent than younger adults)
• Consider patient's cognitive and functional status when designing regimen
• If on complex insulin regimens, simplify to basal-only when appropriate

Renal Impairment:

For patients ≥70 years or eGFR <60 mL/min, consider starting at 0.2-0.3 units/kg (lower end of range) 10.

Common Pitfalls to Avoid

1. Therapeutic inertia: Don't delay titration—adjust every 3 days to 1 week based on glucose patterns 4
2. Discontinuing metformin: Keep metformin unless contraindicated (eGFR <30 mL/min/1.73m²) 2, 3
3. Inadequate titration: Many patients remain on starting doses—titrate aggressively to target 6
4. Using sliding scale alone: Scheduled basal insulin is superior to sliding scale monotherapy 10